| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 2 securities · passive | ||||||
|
OKYO Pharma Ltd
13G
OKYO · G6724L116
|
5.0% |
10/29/2025
Event 7/22/2025
|
||||
|
Tiziana Life Sciences Ltd
13G
TLSA · 88875G101
|
5.7% |
10/28/2025
Event 9/12/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.